No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Iptacopan Reduced Proteinuria in Patients with IgA Nephropathy

byJinny TsangandAlisha Yi

February 13, 2025

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Telitacicept may reduce proteinuria in patients with high-risk IgA nephropathy

Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

Polypharmacy associated with greater risk of mortality and hospitalizations in elderly

RelatedReports

Being overweight and obese associated with increased incidence of chronic kidney disease

Chronic Disease

Telitacicept may reduce proteinuria in patients with high-risk IgA nephropathy

May 26, 2026

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Nephrology

Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis

May 6, 2026

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

March 19, 2026

Solitary kidney not associated with contrast-induced nephropathy

Chronic Disease

Albuminuria shows a stronger association with kidney failure than proteinuria

November 20, 2025

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Magnetic resonance imaging provides important information regarding infarct topography in determining stroke mechanism and risk

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Endovascular therapy improves outcomes in vertebrobasilar stroke despite increased risk of bleeding

Dietary niacin may have a mortality benefit in patients with chronic kidney disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result